Although MRI is the workhorse of initial evaluation and follow-up in brain tumors, there are
growing data recommending incorporation of amino acid PET imaging at different stages in …

PET using radiolabelled amino acids is a rapidly evolving method that can significantly
enhance the diagnostic value of MRI in brain tumours. Current developments suggest that …

Background Amino acid PET imaging of brain tumors has been shown to play an important
role in predicting tumor grade, delineation of tumor margins, and differentiating tumor …

Purpose Amino acid PET is a useful complement to MRI in a number of clinical settings for
the evaluation of brain tumors. However, amino acid PET is rarely used repeatedly over the …

In adults, amino acid PET tracers such as 11 C-methionine and 18 F-DOPA have been used
to obtain important clinical information in newly diagnosed tumors, directly influencing …

Positron emission tomography (PET) is a nuclear medicine imaging method with increasing
relevance for the diagnosis, prognostication, and monitoring of glioblastomas. PET provides …

Amino-acid PET imaging is an efficient complementary tool to MRI for the assessment of
gliomas, principally for high-grade gliomas [1] and is now recommended by the Response …

Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-
enhanced magnetic resonance imaging (MRI). However, the capacity of structural MRI to …

PET with amino acid tracers provides additional insight beyond MR imaging into the biology
of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of …

The objective of this study was to give an overview of the potential clinical utility of [18 F]-L-
dihydroxyphenylalanine (18 F-DOPA) PET and PET/CT for imaging of brain tumors. Review …